Casdin Capital, LLC Codexis, Inc. Transaction History
Casdin Capital, LLC
- $713 Million
- Q2 2025
A detailed history of Casdin Capital, LLC transactions in Codexis, Inc. stock. As of the latest transaction made, Casdin Capital, LLC holds 7,200,000 shares of CDXS stock, worth $20.6 Million. This represents 2.46% of its overall portfolio holdings.
Number of Shares
7,200,000
Previous 8,100,000
11.11%
Holding current value
$20.6 Million
Previous $21.8 Million
19.37%
% of portfolio
2.46%
Previous 2.55%
Shares
15 transactions
Others Institutions Holding CDXS
# of Institutions
130Shares Held
69.2MCall Options Held
25.8KPut Options Held
20K-
Opaleye Management Inc. Boston, MA12.6MShares$36 Million7.35% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$19.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.59MShares$13.1 Million0.0% of portfolio
-
Abrdn PLC4.2MShares$12 Million0.02% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.03MShares$11.5 Million0.43% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $187M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...